Evidence map›Paper›PMID 26354794›Full record

ArticleBMC cancer2015

Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentration.

Muhammad M Hammami, Najla Duaiji, Ghazi Mutairi, Sabah Aklabi, Nasser Qattan, Mohei El-Din M Abouzied, Mohamed W Sous

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Muhammad M HammamiDepartments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Muhammad@kfshrc.edu.sa.
Najla DuaijiDepartments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. dr.duaiji@hotmail.com.
Ghazi MutairiDepartments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. almutairighazi@gmail.com.
Sabah AklabiDepartments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. sabahalaklabi@gmail.com.
Nasser QattanDepartments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. alqattan98@gmail.com.
Mohei El-Din M AbouziedDepartments of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. MAboutaleb@kfshrc.edu.sa.
Mohamed W SousDepartments of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. msous@kfshrc.edu.sa.
King Faisal Specialist Hospital & Research Centre · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNormalization of cortisol concentration by multikinase inhibitors have been reported in three patients with medullary thyroid cancer-related Cushing's syndrome. Aortic dissection has been reported in three patients with Cushing's syndrome. Diabetes insipidus without intrasellar metastasis, intestinal intussusception, and paraneoplastic dysautonomia have not been reported in medullary thyroid cancer. CASE PRESENTATION: An adult male with metastatic medullary thyroid cancer presented with hyperglycemia, hypernatremia, hypokalemia, hypertension, acne-like rash, and diabetes insipidus (urine volume >8 L/d, osmolality 190 mOsm/kg). Serum cortisol, adrenocorticoitropic hormone, dehydroepiandrostenedione sulfate, and urinary free cortisol were elevated 8, 20, 4.4, and 340 folds, respectively. Pituitary imaging was normal. Computed tomography scan revealed jejunal intussusception and incidental abdominal aortic dissection. Sorafenib treatment was associated with Cushing's syndrome remission, elevated progesterone (>10 fold), normalization of dehydroepiandrostenedione sulfate, but persistently elevated cortisol concentration. Newly-developed proximal lower limb weakness and decreased salivation were associated with elevated ganglionic neuronal acetylcholine receptor (alpha-3) and borderline P/Q type calcium channel antibodies.

conclusionExtreme cortisol concentration may have contributed to aortic dissection and suppressed antidiuretic hormone secretion; which combined with hypokalemia due cortisol activation of mineralocorticoid receptors, manifested as diabetes insipidus. This is the first report of paraneoplastic dysautonomia and jejunal intussusception in medullary thyroid cancer, they may be related to medullary thyroid cancer's neuroendocrine origin and metastasis, respectively. Remission of Cushing's syndrome without measurable reduction in cortisol concentration suggests a novel cortisol-independent mechanism of action or assay cross-reactivity. Normalization of dehydroepiandrostenedione sulfate and elevation of progesterone suggest inhibition of 17-hydroxylase and 21-hydroxylase activities by sorafenib.

Indexed as

AdultAntineoplastic AgentsAortic AneurysmAortic DissectionCarcinoma, MedullaryCushing SyndromeDiabetes InsipidusFatal OutcomeHumansHydrocortisoneIntussusceptionJejunal DiseasesMaleNiacinamideParaneoplastic PolyneuropathyPhenylurea CompoundsAntineoplastic AgentsHydrocortisoneNiacinamidePhenylurea CompoundsSorafenib

Identifiers

PMID26354794
PMCPMC4563835
OpenAlexW1831193432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.